Genovis AB logo

Genovis AB

Update in progress

GENO.ST (Stockholm)

  • SectorHealthcare
  • IndustryBiotechnology

Genovis AB develops and sells tools for new therapies and diagnostics across North America, Europe and Asia. Its portfolio includes enzymes and proteases (FabRICATOR, GingisREX, IgASAP, IgMBRAZOR, OpeRATOR, ImpaRATOR, OglyZOR, SialEXO, FucosEXO, GalactEXO, GalNAcEXO, GlyCLICK, GlySERIAS, GlycOCATCH, OmniGLYZOR, PNGase F) and endoglycosidases (GlycINATOR, IgGZERO). It also offers antibodies, kits, cell culture products, bioprocess and gene therapy services, and customized antibody work. Founded 1999, based in Kävlinge, Sweden.

Company

  • MarketStockholm (STO)
  • LocationSweden
  • CEOMr. Fredrik Olsson
  • Founded1999
  • Employees42
  • Websitewww.genovis.com

Identifiers

  • ISINSE0002485979
  • LEI549300T5KGFRYR7ZST20